中国葡萄膜炎诊疗中眼内液检测专家共识(2020年)

2020-09-20 中华医学会眼科学分会 中华眼科杂志.2020.56(9):657‑661.

葡萄膜炎是一类炎性反应性疾病,病因复杂,诊断主要基于临床表现。眼内液检测作为一种有创性检查方法,在临床适用于部分特定类型葡萄膜炎和眼内炎的诊断,同时在获得伦理委员会批准的情况下,可适用于病毒相关葡萄膜

中文标题:

中国葡萄膜炎诊疗中眼内液检测专家共识(2020年)

发布日期:

2020-09-20

简要介绍:

葡萄膜炎是一类炎性反应性疾病,病因复杂,诊断主要基于临床表现。眼内液检测作为一种有创性检查方法,在临床适用于部分特定类型葡萄膜炎和眼内炎的诊断,同时在获得伦理委员会批准的情况下,可适用于病毒相关葡萄膜炎的临床研究。为了规范眼内液检测在临床的应用,中华医学会眼科学分会眼免疫学组制定共识,对眼内液检测的概念、适应证、检测结果的解读以及需要注意的问题提出指导性意见。

下载附件:

(因为版权问题,不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1208781, encodeId=75211208e8176, content=学习学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a25466306, createdName=349087, createdTime=Tue Apr 05 15:50:19 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995438, encodeId=4963995438d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/4898b9d9447c4a8a99b56ae30ddaa457/64b602c8dd9448b8bd886160665ab816.jpg, createdBy=17d45539335, createdName=木由0, createdTime=Fri Jul 02 17:12:01 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919454, encodeId=4cc6919454a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sun Jan 24 14:07:27 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918190, encodeId=89af918190ec, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78945091303, createdName=145d3859m24暂无昵称, createdTime=Tue Jan 19 20:57:27 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892609, encodeId=d7ff89260940, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Sat Oct 17 09:50:45 CST 2020, time=2020-10-17, status=1, ipAttribution=)]
    2022-04-05 349087

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1208781, encodeId=75211208e8176, content=学习学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a25466306, createdName=349087, createdTime=Tue Apr 05 15:50:19 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995438, encodeId=4963995438d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/4898b9d9447c4a8a99b56ae30ddaa457/64b602c8dd9448b8bd886160665ab816.jpg, createdBy=17d45539335, createdName=木由0, createdTime=Fri Jul 02 17:12:01 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919454, encodeId=4cc6919454a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sun Jan 24 14:07:27 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918190, encodeId=89af918190ec, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78945091303, createdName=145d3859m24暂无昵称, createdTime=Tue Jan 19 20:57:27 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892609, encodeId=d7ff89260940, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Sat Oct 17 09:50:45 CST 2020, time=2020-10-17, status=1, ipAttribution=)]
    2021-07-02 木由0

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1208781, encodeId=75211208e8176, content=学习学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a25466306, createdName=349087, createdTime=Tue Apr 05 15:50:19 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995438, encodeId=4963995438d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/4898b9d9447c4a8a99b56ae30ddaa457/64b602c8dd9448b8bd886160665ab816.jpg, createdBy=17d45539335, createdName=木由0, createdTime=Fri Jul 02 17:12:01 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919454, encodeId=4cc6919454a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sun Jan 24 14:07:27 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918190, encodeId=89af918190ec, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78945091303, createdName=145d3859m24暂无昵称, createdTime=Tue Jan 19 20:57:27 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892609, encodeId=d7ff89260940, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Sat Oct 17 09:50:45 CST 2020, time=2020-10-17, status=1, ipAttribution=)]
    2021-01-24 wuxiaoman

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1208781, encodeId=75211208e8176, content=学习学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a25466306, createdName=349087, createdTime=Tue Apr 05 15:50:19 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995438, encodeId=4963995438d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/4898b9d9447c4a8a99b56ae30ddaa457/64b602c8dd9448b8bd886160665ab816.jpg, createdBy=17d45539335, createdName=木由0, createdTime=Fri Jul 02 17:12:01 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919454, encodeId=4cc6919454a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sun Jan 24 14:07:27 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918190, encodeId=89af918190ec, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78945091303, createdName=145d3859m24暂无昵称, createdTime=Tue Jan 19 20:57:27 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892609, encodeId=d7ff89260940, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Sat Oct 17 09:50:45 CST 2020, time=2020-10-17, status=1, ipAttribution=)]
    2021-01-19 145d3859m24暂无昵称

    学习!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1208781, encodeId=75211208e8176, content=学习学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45a25466306, createdName=349087, createdTime=Tue Apr 05 15:50:19 CST 2022, time=2022-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995438, encodeId=4963995438d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/4898b9d9447c4a8a99b56ae30ddaa457/64b602c8dd9448b8bd886160665ab816.jpg, createdBy=17d45539335, createdName=木由0, createdTime=Fri Jul 02 17:12:01 CST 2021, time=2021-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919454, encodeId=4cc6919454a8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VwTXdecYLXvZSAoWsianaI225JgicDPWFvfm7wzWmKhrIzEV8KnwVAO7I2LgekUjMpiaSrDz63pY6Wkic1VbvmYfOg/132, createdBy=93122504058, createdName=wuxiaoman, createdTime=Sun Jan 24 14:07:27 CST 2021, time=2021-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918190, encodeId=89af918190ec, content=学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78945091303, createdName=145d3859m24暂无昵称, createdTime=Tue Jan 19 20:57:27 CST 2021, time=2021-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892609, encodeId=d7ff89260940, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/13/bce116f3143d02835c5907e0ad2b13a1.jpg, createdBy=a9551679187, createdName=kenblue, createdTime=Sat Oct 17 09:50:45 CST 2020, time=2020-10-17, status=1, ipAttribution=)]
    2020-10-17 kenblue

    认真学习

    0

拓展阅读

2018 欧洲共识建议:少年特发性关节炎相关性葡萄膜炎的管理

国外风湿免疫科相关专家小组 · 2018-03-28

2019 ACR/AF指南:幼年特发性关节炎相关性葡萄膜炎的筛查,监测和治疗

美国风湿病学会(ACR,American College of Rheumatology) · 2019-04-25

2022 中国台湾专家共识:葡萄膜炎患者的分步诊断方法

中国眼科相关专家组(统称) · 2022-03-18

葡萄膜炎患者的循序渐进诊断方法--台湾专家共识

Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan · 2022-02-07

2023 SER建议:葡萄膜炎的治疗

西班牙风湿病学会(SSR,Spanish Society of Rheumatology) · 2023-10-13